APO RESEARCH · REPORT
Parallel Bioreactors
Parallel bioreactors offer advanced controller functionalities designed to meet demanding requirements in both research and process development, as well as for media optimisation and screening studies.
Product & engineering
Understand the product.
Parallel bioreactors offer advanced controller functionalities designed to meet demanding requirements in both research and process development, as well as for media optimisation and screening studies.
Selected research
Industry Research
Parallel Bioreactors Industry Research Report 2026
Market perspective
Parallel bioreactors offer advanced controller functionalities designed to meet demanding requirements in both research and process development, as well as for media optimisation and screening studies.
Several top companies currently account for more than 83% of the total market share and are expected to retain their dominating hold over the market during the forecast period.
Report Scope
Read the full market overview
This report quantifies the global Parallel Bioreactors market in revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Parallel Bioreactors.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Parallel Bioreactors Market by Company
Sartorius
Eppendorf
Infors AG
H.E.L
Solida Biotech
Swiss System Technik AG
Cleaver Scientific Details
HiTec Zang GmbH Details
2mag AG
Solaris Biotechnology
T&J Bio-engineering
Jiangsu KeHai Biological
Parallel Bioreactors Segment by Type
4 Bioreactors
8 Bioreactors
16 Bioreactors
Others
Parallel Bioreactors Segment by Application
Pharmaceutical Industry
Biochemical Engineering
Food Industry
Others
Parallel Bioreactors Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Parallel Bioreactors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Parallel Bioreactors and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Parallel Bioreactors.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Parallel Bioreactors manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Parallel Bioreactors by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Parallel Bioreactors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 4 Bioreactors
- 8 Bioreactors
- 16 Bioreactors
- Others
Applications
- Pharmaceutical Industry
- Biochemical Engineering
- Food Industry
- Others
Companies covered
- Sartorius
- Eppendorf
- Infors AG
- H.E.L
- Solida Biotech
- Swiss System Technik AG
- Cleaver Scientific Details
- HiTec Zang GmbH Details
- 2mag AG
- Solaris Biotechnology
- T&J Bio-engineering
- Jiangsu KeHai Biological
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Parallel Bioreactors by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 4 Bioreactors
- 2.2.3 8 Bioreactors
- 2.2.4 16 Bioreactors
- 2.2.5 Others
- 2.3 Parallel Bioreactors by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Pharmaceutical Industry
- 2.3.3 Biochemical Engineering
- 2.3.4 Food Industry
- 2.3.5 Others
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Parallel Bioreactors Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Parallel Bioreactors Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Parallel Bioreactors Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Parallel Bioreactors Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Parallel Bioreactors Production by Manufacturers (2021-2026)
- 3.2 Global Parallel Bioreactors Production Value by Manufacturers (2021-2026)
- 3.3 Global Parallel Bioreactors Average Price by Manufacturers (2021-2026)
- 3.4 Global Parallel Bioreactors Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Parallel Bioreactors Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Parallel Bioreactors Manufacturers, Product Type & Application
- 3.7 Global Parallel Bioreactors Manufacturers Established Date
- 3.8 Global Parallel Bioreactors Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Sartorius
- 4.1.1 Sartorius Parallel Bioreactors Company Information
- 4.1.2 Sartorius Parallel Bioreactors Business Overview
- 4.1.3 Sartorius Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.1.4 Sartorius Product Portfolio
- 4.1.5 Sartorius Recent Developments
- 4.2 Eppendorf
- 4.2.1 Eppendorf Parallel Bioreactors Company Information
- 4.2.2 Eppendorf Parallel Bioreactors Business Overview
- 4.2.3 Eppendorf Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.2.4 Eppendorf Product Portfolio
- 4.2.5 Eppendorf Recent Developments
- 4.3 Infors AG
- 4.3.1 Infors AG Parallel Bioreactors Company Information
- 4.3.2 Infors AG Parallel Bioreactors Business Overview
- 4.3.3 Infors AG Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.3.4 Infors AG Product Portfolio
- 4.3.5 Infors AG Recent Developments
- 4.4 H.E.L
- 4.4.1 H.E.L Parallel Bioreactors Company Information
- 4.4.2 H.E.L Parallel Bioreactors Business Overview
- 4.4.3 H.E.L Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.4.4 H.E.L Product Portfolio
- 4.4.5 H.E.L Recent Developments
- 4.5 Solida Biotech
- 4.5.1 Solida Biotech Parallel Bioreactors Company Information
- 4.5.2 Solida Biotech Parallel Bioreactors Business Overview
- 4.5.3 Solida Biotech Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.5.4 Solida Biotech Product Portfolio
- 4.5.5 Solida Biotech Recent Developments
- 4.6 Swiss System Technik AG
- 4.6.1 Swiss System Technik AG Parallel Bioreactors Company Information
- 4.6.2 Swiss System Technik AG Parallel Bioreactors Business Overview
- 4.6.3 Swiss System Technik AG Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.6.4 Swiss System Technik AG Product Portfolio
- 4.6.5 Swiss System Technik AG Recent Developments
- 4.7 Cleaver Scientific Details
- 4.7.1 Cleaver Scientific Details Parallel Bioreactors Company Information
- 4.7.2 Cleaver Scientific Details Parallel Bioreactors Business Overview
- 4.7.3 Cleaver Scientific Details Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.7.4 Cleaver Scientific Details Product Portfolio
- 4.7.5 Cleaver Scientific Details Recent Developments
- 4.8 HiTec Zang GmbH Details
- 4.8.1 HiTec Zang GmbH Details Parallel Bioreactors Company Information
- 4.8.2 HiTec Zang GmbH Details Parallel Bioreactors Business Overview
- 4.8.3 HiTec Zang GmbH Details Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.8.4 HiTec Zang GmbH Details Product Portfolio
- 4.8.5 HiTec Zang GmbH Details Recent Developments
- 4.9 2mag AG
- 4.9.1 2mag AG Parallel Bioreactors Company Information
- 4.9.2 2mag AG Parallel Bioreactors Business Overview
- 4.9.3 2mag AG Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.9.4 2mag AG Product Portfolio
- 4.9.5 2mag AG Recent Developments
- 4.10 Solaris Biotechnology
- 4.10.1 Solaris Biotechnology Parallel Bioreactors Company Information
- 4.10.2 Solaris Biotechnology Parallel Bioreactors Business Overview
- 4.10.3 Solaris Biotechnology Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.10.4 Solaris Biotechnology Product Portfolio
- 4.10.5 Solaris Biotechnology Recent Developments
- 4.11 T&J Bio-engineering
- 4.11.1 T&J Bio-engineering Parallel Bioreactors Company Information
- 4.11.2 T&J Bio-engineering Parallel Bioreactors Business Overview
- 4.11.3 T&J Bio-engineering Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.11.4 T&J Bio-engineering Product Portfolio
- 4.11.5 T&J Bio-engineering Recent Developments
- 4.12 Jiangsu KeHai Biological
- 4.12.1 Jiangsu KeHai Biological Parallel Bioreactors Company Information
- 4.12.2 Jiangsu KeHai Biological Parallel Bioreactors Business Overview
- 4.12.3 Jiangsu KeHai Biological Parallel Bioreactors Production, Value and Gross Margin (2021-2026)
- 4.12.4 Jiangsu KeHai Biological Product Portfolio
- 4.12.5 Jiangsu KeHai Biological Recent Developments
5 Global Parallel Bioreactors Production by Region
- 5.1 Global Parallel Bioreactors Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Parallel Bioreactors Production by Region: 2021-2032
- 5.2.1 Global Parallel Bioreactors Production by Region: 2021-2026
- 5.2.2 Global Parallel Bioreactors Production Forecast by Region (2027-2032)
- 5.3 Global Parallel Bioreactors Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Parallel Bioreactors Production Value by Region: 2021-2032
- 5.4.1 Global Parallel Bioreactors Production Value by Region: 2021-2026
- 5.4.2 Global Parallel Bioreactors Production Value Forecast by Region (2027-2032)
- 5.5 Global Parallel Bioreactors Market Price Analysis by Region (2021-2026)
- 5.6 Global Parallel Bioreactors Production and Value, YOY Growth
- 5.6.1 North America Parallel Bioreactors Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Parallel Bioreactors Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Parallel Bioreactors Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Parallel Bioreactors Production Value Estimates and Forecasts (2021-2032)
6 Global Parallel Bioreactors Consumption by Region
- 6.1 Global Parallel Bioreactors Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Parallel Bioreactors Consumption by Region (2021-2032)
- 6.2.1 Global Parallel Bioreactors Consumption by Region: 2021-2026
- 6.2.2 Global Parallel Bioreactors Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Parallel Bioreactors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Parallel Bioreactors Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Parallel Bioreactors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Parallel Bioreactors Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Parallel Bioreactors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Parallel Bioreactors Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Parallel Bioreactors Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Parallel Bioreactors Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Parallel Bioreactors Production by Type (2021-2032)
- 7.1.1 Global Parallel Bioreactors Production by Type (2021-2032) & (K Units)
- 7.1.2 Global Parallel Bioreactors Production Market Share by Type (2021-2032)
- 7.2 Global Parallel Bioreactors Production Value by Type (2021-2032)
- 7.2.1 Global Parallel Bioreactors Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Parallel Bioreactors Production Value Market Share by Type (2021-2032)
- 7.3 Global Parallel Bioreactors Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Parallel Bioreactors Production by Application (2021-2032)
- 8.1.1 Global Parallel Bioreactors Production by Application (2021-2032) & (K Units)
- 8.1.2 Global Parallel Bioreactors Production Market Share by Application (2021-2032)
- 8.2 Global Parallel Bioreactors Production Value by Application (2021-2032)
- 8.2.1 Global Parallel Bioreactors Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Parallel Bioreactors Production Value Market Share by Application (2021-2032)
- 8.3 Global Parallel Bioreactors Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Parallel Bioreactors Value Chain Analysis
- 9.1.1 Parallel Bioreactors Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Parallel Bioreactors Production Mode & Process
- 9.2 Parallel Bioreactors Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Parallel Bioreactors Distributors
- 9.2.3 Parallel Bioreactors Customers
10 Global Parallel Bioreactors Analyzing Market Dynamics
- 10.1 Parallel Bioreactors Industry Trends
- 10.2 Parallel Bioreactors Industry Drivers
- 10.3 Parallel Bioreactors Industry Opportunities and Challenges
- 10.4 Parallel Bioreactors Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst